Brief: Sunshine Biopharma Signs Exclusive Worldwide License For PLpro-Based COVID-19 Treatment

Sunshine Biopharma

28/02/2023 14:11

Feb 28 (Reuters) - Sunshine Biopharma Inc  SBFM.O :
    * SUNSHINE BIOPHARMA INC-SIGNS EXCLUSIVE WORLDWIDE LICENSE
WITH
UNIVERSITY OF ARIZONA FOR PLPRO-BASED COVID-19 TREATMENT

Further company coverage:  SBFM.O 

 ((Reuters.Briefs@thomsonreuters.com;))